Chinese investor funds UK flu trial

Move comes after one of the worst epidemics in recent years

A Chinese venture capital company is injecting cash into a United Kingdom biotech company that is trialing a "universal" vaccine that promises to protect against all major types of flu.

Oxford-based Vaccitech hopes its new vaccine will put an end to the annual arms race between vaccine manufacturers and the viruses that cause influenza, or flu.